scispace - formally typeset
A

Alexander G. Logan

Researcher at Mount Sinai Hospital, Toronto

Publications -  24
Citations -  1826

Alexander G. Logan is an academic researcher from Mount Sinai Hospital, Toronto. The author has contributed to research in topics: Blood pressure & Prehypertension. The author has an hindex of 13, co-authored 24 publications receiving 1546 citations. Previous affiliations of Alexander G. Logan include Mount Sinai Hospital.

Papers
More filters
Journal ArticleDOI

Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children

Kara Nerenberg, +82 more
TL;DR: All individuals with hypertension should have an assessment of global cardiovascular risk to promote health behaviours that lower blood pressure, and an angiotensin receptor-neprilysin inhibitor combination should be used in place of either an ang Elliotensin-converting enzyme inhibitor or angiotENSin receptor blocker in individuals with heart failure.
Journal ArticleDOI

Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex

TL;DR: In patients with refractory hypertension, acute abolition of obstructive sleep apnoea by continuous positive airway pressure reduces nocturnal blood pressure, and data suggest that continuous positiveAirway pressure may reduce no Nocturnal and daytime systolic blood pressure chronically.
Journal ArticleDOI

Effect of Home Blood Pressure Telemonitoring With Self-Care Support on Uncontrolled Systolic Hypertension in Diabetics

TL;DR: Home blood pressure telemonitoring combined with automated self-care support reduced the blood pressure of diabetic patients with uncontrolled systolic hypertension and improved hypertension control and was obtained without the use of more or different antihypertensive medications or additional clinic visits to physicians.
Journal ArticleDOI

Risks and benefits of β-receptor blockers for pregnancy hypertension: overview of the randomized trials

TL;DR: It is not clear that the benefits outweigh the risks when beta-blockers are used to treat mild to moderate chronic or pregnancy-induced hypertension, given the unknown overall effect on perinatal outcomes.